1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29689091 | Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients. | 2018 | 3 |